Because obviously they’re going to sign Yasiel Puig next year...all the Cubans (after Grandal, whose value was diminished by the postseason)!
In all seriousness, Puig in terms of name recognition/marketing and at a much lower price tag is more of a Sox move than Harper.
He’s somewhere between Belle and Machado on the character scale. And he would only be 28 next offseason, so that would work as well with the timeline.
I’m not sure who else would move the scale. Arenado, maybe. Definitely not Rendon. Paul Goldschmidt, perhaps. We’re obviously not getting Trout. Ohtani would be another due to the Japanese media/marketing. I only mention Puig because he seems 5x or 10x more likely from a “Sox historical perspective” than Harper.
He’s closer to the competing in 2020/21 timeline, too.
18.6 fWAR over 6 seasons, average of 3.1, with incredible variance...much like Harper, ranging from 5.1 to 1.1. Also similar to Harper, some of his biggest numbers were in his first couple of seasons in the big leagues. The problem is the last 4 years of Puig gives you a 2.4-2.5 average, but the last two an improved 3.2, which is worth how much to the White Sox?
If you eliminate Harper’s 10 fWAR outlier season, he’s just 17.5 fWAR for 6 seasons, which is 1.1 less than Puig’s, actually. And 3 of Harper’s 7 best seasons were in his first four, another troubling sign.
Yet Harper will get $400 million...it would seem MUCH wiser to sign the equivalent of 4 Puigs (one veteran starting pitcher, one elite reliever and someone like Grandal.)
That way you’re adding 10-12, hopefully 15 fWAR at the same price in terms of total contract dollars as one Harper...and you’re spreading out that risk (or at least mitigating it) across 3-5 guys instead of putting all your eggs in one basket.
Even a lineup with Grandal and Puig at $120-150 million should put up the bigger numbers than Harper at $400...and you still have roughly $250 million to play with, Rodon left to trade, maybe Abreu and the #3 pick in the draft.